219923-85-0

Basic information

• Product Name: PRAMICONAZOLE
• Synonyms: PRAMICONAZOLE;2-IMidazolidinone, 1-[4-[4-[4-[[(2S,4R)-4-(2,4-difluorophenyl)-4-(1H-1,2,4-triazol-1-ylMethyl)-1,3-dioxolan-2-yl]Methoxy]phenyl]-1-piperazinyl]phenyl]-3-(1-Methylethyl)-
• CAS NO: 219923-85-0
• Molecular Formula: C35H39F2N7O4
• Molecular Weight: 659.734
• Mol File: 219923-85-0.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: PRAMICONAZOLE(CAS DataBase Reference)
• NIST Chemistry Reference: PRAMICONAZOLE(219923-85-0)
• EPA Substance Registry System: PRAMICONAZOLE(219923-85-0)

Safety Data

• Hazardous Substances Data: 219923-85-0(Hazardous Substances Data)

Usage

Uses

Antifungal agent.

Upstream product

• 219923-97-4 (2S)-cis-1-[[2-(bromomethyl)-4-(2,4-difluorophenyl)-1,3-dioxolan-4-yl]methyl]-1H-1,2,4-triazole 
• 95182-62-0 1-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3-(1-methylethyl)-2-imidazolidinone 
• 847952-06-1 2-(2,4-difluoro-phenyl)-2-hydroxy-3-[1,2,4]triazol-1-yl-propionic acid 
• 847951-96-6 1,3-dihydro-1-[4-[4-(4-methoxyphenyl)-1-piperazinyl]phenyl]-3-(1-methylethyl)-2H-imidazol-2-one 
• 95182-50-6 1-[4-[4-(4-methoxyphenyl)-1-piperazinyl]phenyl]-3-(1-methylethyl)-2-oxoimidazolidine 
• 86386-76-7 1-[2-(2,4-difluorophenyl)-2,3-epoxypropyl]-1H-1,2,4-triazole 
• 74852-62-3 4-[4-(4-methoxy-phenyl)-piperazin-1-yl]-phenylamine 
• 74853-06-8 phenyl (4-(4-(4-methoxyphenyl)piperazin-1-yl)phenyl)carbamate 
• 86404-63-9 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazolyl)ethanone 
• 118689-07-9 (S)-(+)-2(2,4-Difluorophenyl)-3-(1,2,4-triazol-1-yl)-1,2-propanediol 
• 219923-96-3 (2R)-cis-1-[[2-(bromomethyl)-4-(2,4-difluorophenyl)-1,3-dioxolan-4-yl]methyl]-1H-1,2,4-triazole 

Relevant articles and documents

Synthesis and in vitro and in vivo structure-activity relationships of novel antifungal triazoles for dermatology

In search for new compounds with potential for clinical use as antifungal agents in dermatology, a series of 12 azole compounds were synthesized stereospecifically and investigated specifically for their activity against dermatophyte fungal infections in

2,4,4-trisubstituted-1,3-dioxolane antifungals

The present invention concerns novel compounds of formula a N-oxide form, a pharmaceutically acceptable acid addition salt or a stereochemically isomeric form thereof, wherein n is zero, 1, 2 or 3; X is N or CH; each R1independently is halo, ni